Home › Genedata Biologics 4.0 Enables Large-Scale Design, Synthesis, And Testing Of Bispecific Antibodies
 

Keywords :   


Genedata Biologics 4.0 Enables Large-Scale Design, Synthesis, And Testing Of Bispecific Antibodies

2014-04-02 06:26:51| drugdiscoveryonline News Articles

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the release of Genedata Biologics™ 4.0, the latest version of its enterprise workflow support and data management solution for biologics R&D

Tags: design testing enables synthesis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05BT scraps digital landline switch deadline
20.05Essie Introduces Nail Art Studio
20.05Ilia Beauty Introduces Vegan Lip Sketch Hydrating Crayon
20.05Summer interest rate cut possible, says Bank deputy
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Farm Progress America, May 20, 2024
More »